MedElevator Войти в исследования
← Поиск публикаций

DOI 10.6002/ect.2022.0227

Медицинская библиотека · Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation · 2023

The Glasgow Experience of Extended Myocardial Protection: A Novel Method of Implantation to Reduce Primary Graft Dysfunction After Heart Transplant.

Singh Sanjeet Avtaar, Das De Sudeep, Morcos Karim, Hegazy Yasser, Al-Haideri Hazim, Dalzell Jonathan R, Berry Colin, Doshi Harikrishna, Al-Attar Nawwar, Curry Philip

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

Around 2000 heart transplants are performed in Europe annually. The rates of primary graft dysfunction in Europe are among the highest in the world. With increasing demand for organs and the limited supply of donors, novel techniques such as ex vivo normothermic perfusion have garnered incre-asing interest. We present a series of patients who underwent heart transplant at our unit in which we used a novel implantation technique to reduce primary graft dysfunction.

MATERIALS AND

METHODS

We compared our experience with the novel method detailed in our article (Glasgow experience group) with a contemporary UK cohort (2015-2016) of patients (control group). We performed multivariable logistic regression to compare the Glasgow experience with the control group with primary graft dysfunction as the outcome measure. We adjusted for donor age, recipient diabetes mellitus, urgent listing status, bypass time, and total ischemic time.

RESULTS

Among 194 patients in both cohorts, 140 patients (72.1%) were men and 36 (18.6%) had ischemic cardiomyopathy. The odds ratio of primary graft dysfunction in the control group was 2.99 (95% CI, 1.02- 8.75) compared with the Glasgow experience group.

CONCLUSIONS

Our novel approach was associated with significant reductions in primary graft dysfunction, with a trend toward improved 1-year survival. Larger studies are needed to show differences after further adjustment for known confounders of primary graft dysfunction. We believe this novel technique is safe, cost-effective, and reproducible.

Для цитирования: Singh Sanjeet Avtaar, Das De Sudeep, Morcos Karim, Hegazy Yasser, Al-Haideri Hazim, Dalzell Jonathan R, Berry Colin, Doshi Harikrishna, Al-Attar Nawwar, Curry Philip. The Glasgow Experience of Extended Myocardial Protection: A Novel Method of Implantation to Reduce Primary Graft Dysfunction After Heart Transplant.. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 2023. DOI: 10.6002/ect.2022.0227.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.